Company intelligence / Profile preview

NAEJA Pharmaceutical

Edmonton, Alberta, Canadanaeja.com ↗

Ownership: Private
Employees: ~34
Development stage: Other

Overview

NAEJA Pharmaceutical is a Canadian CRO and early-stage drug discovery company with a focus on developing novel small molecule therapeutics targeting antimicrobial resistance. Its pipeline has included preclinical candidates for bacterial and fungal infections, but no clinical results have been reported publicly as of June 2025.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

AstraZeneca Canada Inc. (notable $10M+ partnership for pain management compound discovery)

Beyond the preview

Go deeper on NAEJA Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAEJA Pharmaceutical.